Stay updated on Expanded Access to Upadacitinib Clinical Trial

Sign up to get notified when there's something new on the Expanded Access to Upadacitinib Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Expanded Access to Upadacitinib Clinical Trial page

  1. Check
    4 days ago
    No Change Detected
  2. Check
    11 days ago
    No Change Detected
  3. Check
    18 days ago
    Change Detected
    Summary
    403 Forbidden error now replaces the study record content, blocking access to the trial’s details and related information. The deletions indicate that a substantial amount of trial content was removed from the page, leaving only basic navigation and the footer visible.
    Difference
    16%
    Check dated 2026-09-21T22:25:45.000Z thumbnail image
  4. Check
    25 days ago
    Change Detected
    Summary
    Visual refresh of the Study Details page with updated layout and styling. The underlying study information and eligibility criteria remain unchanged.
    Difference
    0.3%
    Check dated 2026-09-14T19:34:25.000Z thumbnail image
  5. Check
    32 days ago
    Change Detected
    Summary
    No textual changes were detected; the page's Expanded Access details for Upadacitinib remain unchanged.
    Difference
    0.3%
    Check dated 2026-09-07T20:44:51.000Z thumbnail image
  6. Check
    39 days ago
    Change Detected
    Summary
    The page revision has been bumped from v3.6.5 to v3.6.6, indicating a newer version of the page has been published.
    Difference
    0.3%
    Check dated 2026-08-31T17:22:47.000Z thumbnail image
  7. Check
    46 days ago
    Change Detected
    Summary
    Expanded Access page now lists additional eligible conditions for Upadacitinib (e.g., Hidradenitis Suppurativa, Vitiligo, Alopecia Areata, Systemic Lupus Erythematosus, Giant Cell Arteritis, Spondyloarthritis, Axial Spondyloarthritis, Psoriatic Arthritis, Rheumatoid Arthritis) and updates related MeSH terms. Older date entries (2026-01-30, 2026-01-29, 2025-04) were removed.
    Difference
    5%
    Check dated 2026-08-24T15:57:42.000Z thumbnail image
  8. Check
    61 days ago
    Change Detected
    Summary
    The page revision was updated from v3.6.4 to v3.6.5, indicating a small platform update to the UI/backend. No study details or user actions are altered by this change.
    Difference
    0.1%
    Check dated 2026-08-10T01:42:10.000Z thumbnail image

Stay in the know with updates to Expanded Access to Upadacitinib Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Expanded Access to Upadacitinib Clinical Trial page.